Ather Energy Ltd. makes a corporate announcement

Assuming you mean the warrant component of Ather Energy’s board-approved preferential issue—the filing describes this as up to 79,36,507 warrants aggregating approximately Rs 1,000 Crores, rather than a dollar-denominated tranche—the terms were:

• Exercise/conversion price: Each warrant carries an all-in issue price of Rs 1,260 and converts into one fully paid equity share. Of this, Rs 315 per warrant—25%—was payable on subscription, while the remaining Rs 945 per warrant—75%, expressly termed the “Warrant Conversion Price”—was payable when the warrant was exercised. ^[1]
• Conversion window: The holder could convert the warrants, in one or more tranches, at its option, by giving written notice to Ather, on or before 18 months from the date of warrant allotment. The corresponding shares would be allotted after receipt of the applicable conversion payment. ^[2]
• Conditions precedent: The issue was subject to shareholder approval and other required regulatory/statutory approvals. The detailed resolution also required the preferential offer to be made only after receipt of in-principle approval from the stock exchanges, with allotment subject to the applicable SEBI ICDR and other laws. ^{[3] [2]}
• Consequence of non-exercise: Any warrants not converted within the 18-month period would lapse, and the Rs 315 upfront subscription amount would be forfeited. ^[2]

The warrants were therefore not a conventional fixed-price option with only a future exercise payment: the effective total subscription price was Rs 1,260 per share, split between the upfront Rs 315 and the Rs 945 payable on conversion.

The board resolution does not disclose a specific capex-versus-working-capital split. The relevant resolution is for an INR 1,200-crore preferential issue, with the proceeds allocated as follows:

† Derived as allocation divided by Rs 1,200 Crores.

The Rs 300-crore general corporate-purpose pool is the only bucket that can cover working capital or additional capital expenditure, but the resolution does not state how much will go to either. Therefore:

• Dedicated manufacturing-capex allocation: not separately specified.
• Dedicated working-capital allocation: not separately specified.
• Maximum flexible pool potentially available for both: Rs 300 Crores, or 25% of the issue, subject to the permitted use of proceeds. ^[4]

Comparison with the IPO offer-document funding plan

The IPO offer-document schedule was materially more capex-led. It allocated Rs 927.20 Crores to establishing an E2W factory in Maharashtra, Rs 750 Crores to R&D, Rs 300 Crores to marketing, Rs 498.80 Crores to general corporate purposes, Rs 40 Crores to debt repayment and Rs 110 Crores to issue expenses, for total IPO proceeds of Rs 2,626 Crores. ^[6]

The alignment is therefore complementary rather than a direct continuation of the IPO capex plan:

• The IPO plan explicitly ring-fenced funding for new manufacturing capacity; the current preferential issue does not.
• The current raise places much greater emphasis on debt reduction, with Rs 625 Crores earmarked for borrowings versus Rs 40 Crores in the IPO plan. ^{[4] [6]}
• Marketing remains a substantial requirement, at Rs 275 Crores currently versus Rs 300 Crores under the IPO plan. ^{[5] [6]}
• Working capital remains embedded within broad corporate-purpose funding rather than being quantified separately.

Bottom line: the resolution supports balance-sheet repair and commercial scaling first. It does not establish that Rs 125 million—or any equivalent amount—is specifically funding new manufacturing capacity or working capital. Any precise capex/working-capital split would require a subsequent utilisation statement or monitoring-agency report.

The post-money valuation cannot be calculated from a USD 125 million round alone. The missing input is the percentage of the company issued to the new investors:

`Post-money valuation = USD 125 million / ownership percentage sold`

For example, a 10% primary issuance would imply USD 1.25 billion post-money; a 5% issuance would imply USD 2.5 billion. No ownership percentage, pre-money valuation, share count, or exchange rate is specified here, so an INR valuation comparison would create false precision.

Closest disclosed share-price benchmarks

These prices indicate that the company’s recent institutional and promoter fund-raises were executed within a relatively narrow band of Rs 1,202–Rs 1,260 per share, or approximately 2.23%–7.17% above the Rs 1,175.74 preferential-issue floor. The preferential issue was explicitly priced at a premium to that floor: Rs 1,230 for equity shares and Rs 1,260 for warrants ^[8].

What can and cannot be concluded

• Quantitative valuation comparison: not determinable until the round’s post-issue ownership or share issuance is known.
• Share-price comparison: the relevant official benchmarks currently available are Rs 1,202, Rs 1,230 and Rs 1,260; the DRHP-specific benchmarks and valuation multiples are not present in the cited filing material.
• Fundamental multiple comparison: a forward P/E comparison is not meaningful on the latest reported quarter because consolidated Q1 FY27 PAT was negative at Rs 51.09 Crores, although EBITDA was positive at Rs 9.45 Crores on revenue of Rs 1,216.9 Crores ^[9]. A revenue or EV/EBITDA comparison would still require the round’s implied equity value, net debt and dilution.
• Market-cap cross-check: an exchange-reported market-cap figure for the comparison date is unavailable, so the post-money value should not be reverse-engineered from share capital or face value.

Accordingly, the defensible conclusion is that the round’s valuation is not yet comparable on an absolute basis. Once the percentage stake sold is known, its implied per-share price or post-money value can be tested against the Rs 1,202 QIP price and the Rs 1,230–Rs 1,260 preferential-issue benchmarks.